448 related articles for article (PubMed ID: 8423531)
1. Cholinergic modulation of N-methyl-D-aspartate-evoked [3H]norepinephrine release from rat cortical slices.
Gonzales RA; Roper LC; Westbrook SL
J Pharmacol Exp Ther; 1993 Jan; 264(1):282-8. PubMed ID: 8423531
[TBL] [Abstract][Full Text] [Related]
2. Ethanol inhibits N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat cortical slices.
Gonzales RA; Woodward JJ
J Pharmacol Exp Ther; 1990 Jun; 253(3):1138-44. PubMed ID: 2162947
[TBL] [Abstract][Full Text] [Related]
3. Effects of nicotinic agonists and antagonists on N-methyl-D-aspartate-induced 3H-norepinephrine release and 3H-(1-[1-(2-thienyl)cyclohexyl]-piperidine) binding in rat hippocampus.
Snell LD; Johnson KM
Synapse; 1989; 3(2):129-35. PubMed ID: 2564704
[TBL] [Abstract][Full Text] [Related]
4. Low-level N-methyl-D-aspartate receptor activation provides a purinergic inhibitory threshold against further N-methyl-D-aspartate-mediated neurotransmission in the cortex.
Craig CG; White TD
J Pharmacol Exp Ther; 1992 Mar; 260(3):1278-84. PubMed ID: 1312166
[TBL] [Abstract][Full Text] [Related]
5. A comparison of N-methyl-D-aspartate-evoked release of adenosine and [3H]norepinephrine from rat cortical slices.
Hoehn K; Craig CG; White TD
J Pharmacol Exp Ther; 1990 Oct; 255(1):174-81. PubMed ID: 2145421
[TBL] [Abstract][Full Text] [Related]
6. Effect of soman on N-methyl-D-aspartate-stimulated [3H]norepinephrine release from rat cortical slices.
Tang HW; Cassel G
Toxicol Lett; 1998 Nov; 99(3):169-73. PubMed ID: 9862282
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic potentiation of excitatory amino acid-evoked dopamine release in mesencephalic cells: specificity for the NMDA response and role of intracellular messengers.
Allaoua H; Chaudieu I; Alonso R; Quirion R; Boksa P
Synapse; 1993 Sep; 15(1):39-47. PubMed ID: 8310424
[TBL] [Abstract][Full Text] [Related]
8. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
Rao TS; Correa LD; Lloyd GK
Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
[TBL] [Abstract][Full Text] [Related]
9. A phencyclidine recognition site is associated with N-methyl-D-aspartate inhibition of carbachol-stimulated phosphoinositide hydrolysis in rat cortical slices.
Gonzales RA; Moerschbaecher JM
Mol Pharmacol; 1989 Jun; 35(6):787-94. PubMed ID: 2543912
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
Sacaan AI; Dunlop JL; Lloyd GK
J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
[TBL] [Abstract][Full Text] [Related]
11. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. II. Evidence for functional cooperation and for coexistence on the same axon terminal.
Raiteri M; Garrone B; Pittaluga A
J Pharmacol Exp Ther; 1992 Jan; 260(1):238-42. PubMed ID: 1370541
[TBL] [Abstract][Full Text] [Related]
12. Cooperative contributions of cholinergic and NMDA receptors in the presynaptic control of dopamine release from synaptosomes of the rat striatum.
Chéramy A; Godeheu G; L'Hirondel M; Glowinski J
J Pharmacol Exp Ther; 1996 Feb; 276(2):616-25. PubMed ID: 8632329
[TBL] [Abstract][Full Text] [Related]
13. Persistent nicotinic blockade by chlorisondamine of noradrenergic neurons in rat brain and cultured PC12 cells.
Reuben M; Louis M; Clarke PB
Br J Pharmacol; 1998 Nov; 125(6):1218-27. PubMed ID: 9863650
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate mediated responses decrease with age in Fischer 344 rat brain.
Gonzales RA; Brown LM; Jones TW; Trent RD; Westbrook SL; Leslie SW
Neurobiol Aging; 1991; 12(3):219-25. PubMed ID: 1678878
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory and potentiating influences of glycine on N-methyl-D-aspartate-evoked dopamine release from cultured rat mesencephalic cells.
Mount H; Quirion R; Chaudieu I; Boksa P
Mol Pharmacol; 1991 Feb; 39(2):205-10. PubMed ID: 1825345
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by soman of NMDA-stimulated [3H]norepinephrine release from rat cortical slices, studies of non-cholinergic effect.
Tang HW; Cassel G
Brain Res; 1998 Mar; 787(1):123-31. PubMed ID: 9518577
[TBL] [Abstract][Full Text] [Related]
17. Characterization of nitric oxide generator-induced hippocampal [3H]norepinephrine release. I. The role of glutamate.
Lonart G; Johnson KM
J Pharmacol Exp Ther; 1995 Oct; 275(1):7-13. PubMed ID: 7562597
[TBL] [Abstract][Full Text] [Related]
18. Activity of putative cognition enhancers in kynurenate test performed with human neocortex slices.
Pittaluga A; Pattarini R; Andrioli GC; Viola C; Munari C; Raiteri M
J Pharmacol Exp Ther; 1999 Jul; 290(1):423-8. PubMed ID: 10381808
[TBL] [Abstract][Full Text] [Related]
19. Serotonergic modulation of L-glutamic acid-evoked release of endogenous norepinephrine from rat hypothalamus.
Goldfarb J; Walcott J; Blandina P
J Pharmacol Exp Ther; 1993 Oct; 267(1):45-50. PubMed ID: 8229775
[TBL] [Abstract][Full Text] [Related]
20. Glycine site antagonists and partial agonists inhibit N-methyl-D-aspartate receptor-mediated [3H]arachidonic acid release in cerebellar granule cells.
Viu E; Zapata A; Capdevila JL; Fossom LH; Skolnick P; Trullas R
J Pharmacol Exp Ther; 1998 May; 285(2):527-32. PubMed ID: 9580593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]